Therefore, our study uncovers an essential role of the USP10/IGF2BP1/CPT1A axis in the regulation of BC metastasis and provides a promising prognostic biomarker and therapeutic target for BC patients with metastasis. This evidence concerns the gene IGF2BP1 and breast cancer.